Franklin Resources
AMRX icon

Franklin Resources’s Amneal Pharmaceuticals AMRX Stock Holding History

Franklin Resources’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.89M Sell
398,189
-39,640
-9% -$543K ﹤0.01% 1443
2026
Q1 		$5.44M Buy
437,829
+23,289
+6% +$313K ﹤0.01% 1484
2025
Q4 		$5.22M Buy
414,540
+320,528
+341% +$3.67M ﹤0.01% 1384
2025
Q3 		$941K Buy
94,012
+4,125
+5% +$37K ﹤0.01% 2136
2025
Q2 		$727K Hold
89,887
– – ﹤0.01% 2149
2025
Q1 		$753K Hold
89,887
– – ﹤0.01% 2089
2024
Q4 		$712K Hold
89,887
– – ﹤0.01% 2134
2024
Q3 		$778K Buy
89,887
+4,178
+5% +$32.7K ﹤0.01% 2088
2024
Q2 		$544K Buy
85,709
+9,868
+13% +$62.6K ﹤0.01% 2190
2024
Q1 		$460K Hold
75,841
– – ﹤0.01% 2295
2023
Q4 		$460K Sell
75,841
-123
-0.2% -$548 ﹤0.01% 1993
2023
Q3 		$321K Buy
+75,964
New +$283K ﹤0.01% 2126

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Franklin Resources's AMRX Position: Q2 2026 in Review

Franklin Resources reduced its Amneal Pharmaceuticals (AMRX) stake by 9.1% in Q2 2026, selling an estimated $543K and leaving 398,189 shares worth $6.89M. The position accounts for ﹤0.01% of the portfolio, ranked #1443.

Franklin Resources first reported a position in AMRX in Q3 2023 and has held it in 12 quarters since. 306 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Franklin Resources held 398,189 shares of Amneal Pharmaceuticals worth $6.89M as of Q2 2026.
  • Franklin Resources sold 39,640 Amneal Pharmaceuticals shares in Q2 2026, an estimated $543K.
  • Amneal Pharmaceuticals made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #1443 holding.
  • Franklin Resources first reported a position in Amneal Pharmaceuticals in Q3 2023 and has held it in 12 quarters since.
  • 306 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.